• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019年9月至2020年2月未接种疫苗和接种疫苗的麻疹患者中循环SARS-CoV-2的早期证据。

Early Evidence of Circulating SARS-CoV-2 in Unvaccinated and Vaccinated Measles Patients, September 2019-February 2020.

作者信息

Paixao Joana, Galangue Maria, Gaston Celestina, Carralero Raísa, Lino Celestina, Júlio Gracieth, David Zinga, Francisco Moises, Sebastião Cruz S, Sacomboio Euclides N M, Morais Joana, Francisco Ngiambudulu M

机构信息

Grupo de Investigação Microbiana e Imunológica, Instituto Nacional de Investigação em Saúde (National Institute for Health Research), Luanda, Angola.

Unidade de Ensino e Investigação de Microbiologia Médica, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisboa, Portugal.

出版信息

Infect Drug Resist. 2022 Feb 19;15:533-544. doi: 10.2147/IDR.S344437. eCollection 2022.

DOI:10.2147/IDR.S344437
PMID:35221698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8865870/
Abstract

BACKGROUND

The global emergence of coronavirus disease 2019 (COVID-19) has challenged healthcare and rapidly spread over the globe. Early detection of new infections is crucial in the control of emerging diseases. Evidence of early recorded COVID-19 cases outside China has been documented in various countries. In this study, we aimed to identify the time of SARS-CoV-2 infection circulation by retrospectively analyzing sera of measles patients, weeks before the reported first COVID-19 cases in Angola.

MATERIALS AND METHODS

We examined the humoral response against SARS-CoV-2 by using an enzyme-linked immunosorbent assay (ELISA)-based assay on a combined two-step sandwich enzyme immunoassay method. In total, we received 568 study patients with blood specimens collected from 23 September 2019 to 28 February 2020, 442 sera samples that met the criteria of the study were withdrawn and selected from the overall 568 received samples. In this study, we considered seropositives, patients who tested positive for SARS-CoV-2 immunoglobulin G (IgG) and M (IgM) antibodies with the index value >1.

RESULTS

Of the 442 sera samples that met the criteria of the study, 204 were measles seropositive. Forty out of 204 were confirmed reactive to SARS-CoV-2 viral proteins using IgG and IgM more than 2 weeks before the first reported case in Angola. The humoral response analysis showed significant differences ( = 0.01) between the IgG and IgM indexes in the unvaccinated measles patients. Similarly, a significant difference ( = 0.001) was seen between the IgG and IgM indexes in the vaccinated measles patients.

CONCLUSION

Here, using the humoral response analysis, we report the identification of early circulation SARS-CoV-2 infection weeks before the first recognized cases in the Republic of Angola.

摘要

背景

2019冠状病毒病(COVID-19)在全球出现,给医疗保健带来了挑战,并在全球迅速传播。新感染的早期检测对于控制新发疾病至关重要。中国以外早期记录的COVID-19病例的证据已在各国得到记录。在本研究中,我们旨在通过回顾性分析安哥拉报告首例COVID-19病例前数周麻疹患者的血清,确定严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的传播时间。

材料与方法

我们采用基于酶联免疫吸附测定(ELISA)的两步夹心酶免疫测定法,检测针对SARS-CoV-2的体液免疫反应。我们共接收了568例研究患者,其血液标本采集于2019年9月23日至2020年2月28日,从总共568份接收样本中提取并选取了442份符合研究标准的血清样本。在本研究中,我们将严重急性呼吸综合征冠状病毒2免疫球蛋白G(IgG)和M(IgM)抗体检测指数值>1的血清反应阳性患者视为血清阳性。

结果

在442份符合研究标准的血清样本中,204份为麻疹血清阳性。在安哥拉报告首例病例前2周多,204份样本中有40份通过IgG和IgM检测证实对SARS-CoV-2病毒蛋白呈反应性。体液免疫反应分析显示,未接种麻疹疫苗患者的IgG和IgM指数之间存在显著差异(P=0.01)。同样,接种麻疹疫苗患者的IgG和IgM指数之间也存在显著差异(P=0.001)。

结论

在此,通过体液免疫反应分析,我们报告了在安哥拉共和国首例确诊病例前数周就已发现SARS-CoV-2感染的早期传播情况。

相似文献

1
Early Evidence of Circulating SARS-CoV-2 in Unvaccinated and Vaccinated Measles Patients, September 2019-February 2020.2019年9月至2020年2月未接种疫苗和接种疫苗的麻疹患者中循环SARS-CoV-2的早期证据。
Infect Drug Resist. 2022 Feb 19;15:533-544. doi: 10.2147/IDR.S344437. eCollection 2022.
2
Molecular evidence for SARS-CoV-2 in samples collected from patients with morbilliform eruptions since late 2019 in Lombardy, northern Italy.来自意大利北部伦巴第地区自 2019 年底以来患有麻疹样皮疹的患者样本中发现的 SARS-CoV-2 的分子证据。
Environ Res. 2022 Dec;215(Pt 1):113979. doi: 10.1016/j.envres.2022.113979. Epub 2022 Aug 25.
3
Impact of heat-inactivation on the detection of SARS-CoV-2 IgM and IgG antibody by ELISA.热失活对 ELISA 检测 SARS-CoV-2 IgM 和 IgG 抗体的影响。
Clin Chim Acta. 2020 Oct;509:288-292. doi: 10.1016/j.cca.2020.06.032. Epub 2020 Jun 20.
4
Evaluation of the Levels of Peripheral CD3, CD4, and CD8 T Cells and IgG and IgM Antibodies in COVID-19 Patients at Different Stages of Infection.评价不同感染阶段 COVID-19 患者外周血 CD3、CD4、CD8 T 细胞及 IgG、IgM 抗体水平。
Microbiol Spectr. 2022 Feb 23;10(1):e0084521. doi: 10.1128/spectrum.00845-21.
5
Serological investigation of SARS-CoV-2 infection in patients with suspect measles, 2017-2022.2017-2022 年疑似麻疹患者中 SARS-CoV-2 感染的血清学调查。
Virol J. 2023 Jul 20;20(1):160. doi: 10.1186/s12985-023-02117-9.
6
Enzyme-Linked Immunosorbent Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) IgM/IgA and IgG Antibodies Among Healthcare Workers.用于检测医护人员中严重急性呼吸综合征冠状病毒2(SARS-CoV-2)IgM/IgA和IgG抗体的酶联免疫吸附测定
Cureus. 2020 Sep 6;12(9):e10285. doi: 10.7759/cureus.10285.
7
Humoral immune responses in hospitalized COVID-19 patients.住院COVID-19患者的体液免疫反应。
Saudi J Biol Sci. 2021 Jul;28(7):4055-4061. doi: 10.1016/j.sjbs.2021.04.032. Epub 2021 Apr 20.
8
Comparison of a rapid immunochromatographic test with a chemiluminescence immunoassay for detection of anti-SARS-CoV-2 IgM and IgG.快速免疫层析法与化学发光免疫分析法检测抗 SARS-CoV-2 IgM 和 IgG 的比较。
Biochem Med (Zagreb). 2020 Oct 15;30(3):030901. doi: 10.11613/BM.2020.030901.
9
Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.COVID-19 患者在疫情早期对 SARS-CoV-2 抗体的动态变化。
Virol Sin. 2020 Dec;35(6):744-751. doi: 10.1007/s12250-020-00268-5. Epub 2020 Jul 27.
10
Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay.酶联免疫吸附试验评价 COVID-19 患者血清 IgM 和 IgG 抗体。
J Med Virol. 2021 May;93(5):2857-2866. doi: 10.1002/jmv.26741. Epub 2021 Mar 1.

引用本文的文献

1
Pre-pandemic antibodies screening against SARS-CoV-2 and virus detection among children diagnosed with eruptive fevers.爆发性发热患儿的 SARS-CoV-2 预流行期抗体筛查和病毒检测。
Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241260633. doi: 10.1177/03946320241260633.
2
Assessment of the yellow fever outbreak in Angola from December 2015 through December 2016: A retrospective study.2015年12月至2016年12月安哥拉黄热病疫情评估:一项回顾性研究。
Health Sci Rep. 2024 Feb 15;7(2):e1924. doi: 10.1002/hsr2.1924. eCollection 2024 Feb.
3
Insights into SARS-CoV-2 in Angola during the COVID-19 peak: Molecular epidemiology and genome surveillance.

本文引用的文献

1
The SARS-CoV-2 spike protein is vulnerable to moderate electric fields.SARS-CoV-2 刺突蛋白易受中等强度电场影响。
Nat Commun. 2021 Sep 13;12(1):5407. doi: 10.1038/s41467-021-25478-7.
2
Early Identification of SARS-CoV-2 Emergence in the Department of Defense via Retrospective Analysis of 2019-2020 Upper Respiratory Illness Samples.通过对 2019-2020 年上呼吸道疾病样本的回顾性分析,提前在国防部发现了 SARS-CoV-2 。
MSMR. 2021 Jun 1;28(6):2-5.
3
Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in All of Us Research Program Participants, 2 January to 18 March 2020.
安哥拉 COVID-19 高峰期间对 SARS-CoV-2 的了解:分子流行病学和基因组监测。
Influenza Other Respir Viruses. 2023 Sep 22;17(9):e13198. doi: 10.1111/irv.13198. eCollection 2023 Sep.
4
Molecular evidence for SARS-CoV-2 in samples collected from patients with morbilliform eruptions since late 2019 in Lombardy, northern Italy.来自意大利北部伦巴第地区自 2019 年底以来患有麻疹样皮疹的患者样本中发现的 SARS-CoV-2 的分子证据。
Environ Res. 2022 Dec;215(Pt 1):113979. doi: 10.1016/j.envres.2022.113979. Epub 2022 Aug 25.
2020 年 1 月 2 日至 3 月 18 日,所有美国人研究计划参与者中严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的抗体。
Clin Infect Dis. 2022 Mar 1;74(4):584-590. doi: 10.1093/cid/ciab519.
4
Strengthened health systems are needed to tackle COVID-19 in Africa.非洲需要加强卫生系统以应对新冠疫情。
Nat Med. 2021 Jul;27(7):1126-1127. doi: 10.1038/s41591-021-01395-6.
5
Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients.在接受 mRNA-1273 疫苗接种者的血浆中检测到循环严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)疫苗抗原。
Clin Infect Dis. 2022 Mar 1;74(4):715-718. doi: 10.1093/cid/ciab465.
6
Skin Manifestation of SARS-CoV-2: The Italian Experience.新型冠状病毒肺炎的皮肤表现:意大利的经验
J Clin Med. 2021 Apr 8;10(8):1566. doi: 10.3390/jcm10081566.
7
SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination.SARS-CoV-2 刺突蛋白决定合胞体介导的淋巴细胞消除。
Cell Death Differ. 2021 Sep;28(9):2765-2777. doi: 10.1038/s41418-021-00782-3. Epub 2021 Apr 20.
8
Sociodemographic characteristics and risk factors related to SARS-CoV-2 infection in Luanda, Angola.安哥拉罗安达的 SARS-CoV-2 感染的社会人口学特征和危险因素。
PLoS One. 2021 Mar 25;16(3):e0249249. doi: 10.1371/journal.pone.0249249. eCollection 2021.
9
Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based "CONSTANCES" cohort.法国早期 SARS-CoV-2 循环的证据:基于人群的“CONSTANCES”队列研究结果。
Eur J Epidemiol. 2021 Feb;36(2):219-222. doi: 10.1007/s10654-020-00716-2. Epub 2021 Feb 6.
10
Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Reactive Antibodies: December 2019-January 2020.美国献血者血清学检测以鉴定严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)反应性抗体:2019 年 12 月-2020 年 1 月。
Clin Infect Dis. 2021 Jun 15;72(12):e1004-e1009. doi: 10.1093/cid/ciaa1785.